244 related articles for article (PubMed ID: 24242034)
1. [Therapeutic concepts in Amyotrophic Lateral Sclerosis (ALS)].
Ludolph AC
Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S21. PubMed ID: 24242034
[No Abstract] [Full Text] [Related]
2. Slowing down ALS--is this good or bad?
Munsat TL
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S19-22. PubMed ID: 11465919
[TBL] [Abstract][Full Text] [Related]
3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
4. Measures of quality of life: pro.
Ludolph AC
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S19. PubMed ID: 12396796
[No Abstract] [Full Text] [Related]
5. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
[TBL] [Abstract][Full Text] [Related]
6. Riluzole.
Gelinas DF
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1 Suppl 4():3-4. PubMed ID: 11466957
[No Abstract] [Full Text] [Related]
7. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
Cudkowicz ME; Katz J; Moore DH; O'Neill G; Glass JD; Mitsumoto H; Appel S; Ravina B; Kieburtz K; Shoulson I; Kaufmann P; Khan J; Simpson E; Shefner J; Levin B; Cwik V; Schoenfeld D; Aggarwal S; McDermott MP; Miller RG
Amyotroph Lateral Scler; 2010 May; 11(3):259-65. PubMed ID: 19961263
[TBL] [Abstract][Full Text] [Related]
8. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
Yanagisawa N; Shindo M
Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
[TBL] [Abstract][Full Text] [Related]
9. [Amyotrophic lateral sclerosis. Fatal diagnosis -- how still can be helped?].
Stiefelhagen P
MMW Fortschr Med; 2004 Nov; 146(47):16. PubMed ID: 15624649
[No Abstract] [Full Text] [Related]
10. Riluzole for the treatment of amyotrophic lateral sclerosis.
Saitoh Y; Takahashi Y
Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
[TBL] [Abstract][Full Text] [Related]
11. [Amyotrophic lateral sclerosis].
Iwanowski L
Neurol Neurochir Pol; 1999; 33(2):445-50. PubMed ID: 10463257
[TBL] [Abstract][Full Text] [Related]
12. Patient page. Treatment and quality of life for people with ALS.
Fletcher J
Neurology; 2004 May; 62(10):E22-3. PubMed ID: 15159521
[No Abstract] [Full Text] [Related]
13. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
[TBL] [Abstract][Full Text] [Related]
14. Management of amyotrophic lateral sclerosis with riluzole.
Neatherlin JS
J Neurosci Nurs; 1998 Aug; 30(4):257-60. PubMed ID: 9791781
[TBL] [Abstract][Full Text] [Related]
15. [Riluzole as a treatment for amyotrophic lateral sclerosis].
Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A
Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030
[TBL] [Abstract][Full Text] [Related]
16. New ideas for therapy in ALS.
Swash M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):3-4. PubMed ID: 16036419
[No Abstract] [Full Text] [Related]
17. Any placebo controlled trial of riluzole would surely be unethical now.
Ford M; Leperlier C
BMJ; 2001 Sep; 323(7312):573-4. PubMed ID: 11573491
[No Abstract] [Full Text] [Related]
18. Riluzole treatment in advanced ALS.
Borasio GD
J Neurol; 2002 May; 249(5):505-6. PubMed ID: 12021937
[No Abstract] [Full Text] [Related]
19. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
[TBL] [Abstract][Full Text] [Related]
20. [Etiological drug therapy for amyotrophic lateral sclerosis].
Cintas P
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
